Sarah T Arron1, Amanda K Raymond, Elizabeth L Yanik, David Castenson, Charles E McCulloch, Christina A Clarke, Lisa E Paddock, Xiaoling Niu, Eric A Engels. 1. *Department of Dermatology University of California, San Francisco, San Francisco, California; †Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; ‡Information Management Services, Rockville, Maryland; §Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, California; ‖Cancer Prevention Institute of California, Fremont, California; ¶Rutgers School of Public Health, Piscataway, New Jersey; #Cancer Epidemiology Services, New Jersey Department of Health, Trenton, New Jersey.
Abstract
BACKGROUND: There are limited data on outcomes in transplant recipients with a history of pretransplant melanoma. OBJECTIVE: To determine whether pretransplant melanoma is associated with differences in survival or posttransplant melanoma risk. MATERIALS AND METHODS: We evaluated the outcomes of 185,039 US transplant recipients from the Transplant Cancer Match Study. We also evaluated the impact of transplantation on 141,441 patients with melanoma identified in cancer registries. RESULTS: There were 336 transplant recipients (0.18%) with pretransplant melanoma; they had increased risk of melanoma-specific mortality (hazard ratio [HR], 27; 95% confidence interval [CI], 11-64, p < .0001), overall mortality (HR, 1.3; 95% CI, 1.0-1.5, p = .02), and incident melanoma (HR, 5.4; 95% CI, 2.9-9.8, p < .0001) after transplant, compared with recipients without pretransplant melanoma. The 10-year absolute risk difference was 2.97% for melanoma-specific mortality, 3.68% for incident melanoma, and 14.32% for overall mortality. Among the 141,441 patients with melanoma in the general population, 68 (0.05%) subsequently received a transplant. Transplantation increased melanoma-specific mortality, but not significantly (HR, 1.7; 95% CI, 0.61-4.5, p = .32). CONCLUSION: Pretransplant melanoma is associated with increased melanoma-specific mortality, overall mortality, and incident melanoma after transplant. Nonetheless, the rarity of melanoma-related events supports the current practice for listing transplant candidates with a history of melanoma.
BACKGROUND: There are limited data on outcomes in transplant recipients with a history of pretransplant melanoma. OBJECTIVE: To determine whether pretransplant melanoma is associated with differences in survival or posttransplant melanoma risk. MATERIALS AND METHODS: We evaluated the outcomes of 185,039 US transplant recipients from the Transplant Cancer Match Study. We also evaluated the impact of transplantation on 141,441 patients with melanoma identified in cancer registries. RESULTS: There were 336 transplant recipients (0.18%) with pretransplant melanoma; they had increased risk of melanoma-specific mortality (hazard ratio [HR], 27; 95% confidence interval [CI], 11-64, p < .0001), overall mortality (HR, 1.3; 95% CI, 1.0-1.5, p = .02), and incident melanoma (HR, 5.4; 95% CI, 2.9-9.8, p < .0001) after transplant, compared with recipients without pretransplant melanoma. The 10-year absolute risk difference was 2.97% for melanoma-specific mortality, 3.68% for incident melanoma, and 14.32% for overall mortality. Among the 141,441 patients with melanoma in the general population, 68 (0.05%) subsequently received a transplant. Transplantation increased melanoma-specific mortality, but not significantly (HR, 1.7; 95% CI, 0.61-4.5, p = .32). CONCLUSION: Pretransplant melanoma is associated with increased melanoma-specific mortality, overall mortality, and incident melanoma after transplant. Nonetheless, the rarity of melanoma-related events supports the current practice for listing transplant candidates with a history of melanoma.
Authors: Jerry D Brewer; Leslie J Christenson; Amy L Weaver; Daniel C Dapprich; Roger H Weenig; Katherine K Lim; John S Walsh; Clark C Otley; Wida Cherikh; Joseph F Buell; E Steve Woodle; Christopher Arpey; Pamela R Patton Journal: Arch Dermatol Date: 2011-07
Authors: Martina Sanlorenzo; Igor Vujic; Christian Posch; Akshay Dajee; Adam Yen; Sarasa Kim; Michelle Ashworth; Michael D Rosenblum; Alain Algazi; Simona Osella-Abate; Pietro Quaglino; Adil Daud; Susanna Ortiz-Urda Journal: Cancer Biol Ther Date: 2014-03-20 Impact factor: 4.742
Authors: R N Matin; D Mesher; C M Proby; J M McGregor; J N Bouwes Bavinck; V del Marmol; S Euvrard; C Ferrandiz; A Geusau; M Hackethal; W L Ho; G F L Hofbauer; B Imko-Walczuk; J Kanitakis; A Lally; J T Lear; C Lebbe; G M Murphy; S Piaserico; D Seckin; E Stockfleth; C Ulrich; F T Wojnarowska; H Y Lin; C Balch; C A Harwood Journal: Am J Transplant Date: 2008-09 Impact factor: 8.086
Authors: Sancy A Leachman; John Carucci; Wendy Kohlmann; Kimberly C Banks; Maryam M Asgari; Wilma Bergman; Giovanna Bianchi-Scarrà; Teresa Brentnall; Brigitte Bressac-de Paillerets; William Bruno; Clara Curiel-Lewandrowski; Femke A de Snoo; Tadeusz Debniak; Marie-France Demierre; David Elder; Alisa M Goldstein; Jane Grant-Kels; Allan C Halpern; Christian Ingvar; Richard F Kefford; Julie Lang; Rona M MacKie; Graham J Mann; Kurt Mueller; Julia Newton-Bishop; Håkan Olsson; Gloria M Petersen; Susana Puig; Darrell Rigel; Susan M Swetter; Margaret A Tucker; Emanuel Yakobson; John A Zitelli; Hensin Tsao Journal: J Am Acad Dermatol Date: 2009-10 Impact factor: 11.527
Authors: Eric A Engels; Ruth M Pfeiffer; Joseph F Fraumeni; Bertram L Kasiske; Ajay K Israni; Jon J Snyder; Robert A Wolfe; Nathan P Goodrich; A Rana Bayakly; Christina A Clarke; Glenn Copeland; Jack L Finch; Mary Lou Fleissner; Marc T Goodman; Amy Kahn; Lori Koch; Charles F Lynch; Margaret M Madeleine; Karen Pawlish; Chandrika Rao; Melanie A Williams; David Castenson; Michael Curry; Ruth Parsons; Gregory Fant; Monica Lin Journal: JAMA Date: 2011-11-02 Impact factor: 157.335
Authors: Mariana P Ferreira; Anna E Coghill; Claudia B Chaves; Anke Bergmann; Luiz C Thuler; Esmeralda A Soares; Ruth M Pfeiffer; Eric A Engels; Marcelo A Soares Journal: AIDS Date: 2017-02-20 Impact factor: 4.177
Authors: Nathaniel C Holcomb; Robert-Marlo Bautista; Stuart G Jarrett; Katharine M Carter; Madeline Krentz Gober; John A D'Orazio Journal: Adv Protein Chem Struct Biol Date: 2018-12-05 Impact factor: 3.507
Authors: Eric A Engels; Gregory Haber; Allyson Hart; Charles F Lynch; Jie Li; Karen S Pawlish; Baozhen Qiao; Kelly J Yu; Ruth M Pfeiffer Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-04-29 Impact factor: 4.090